| Financial Year |
March 31 2023 |
| Monetary Funds |
790,655,933.48 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
9,036,451.76 |
| Accounts Receivable |
683,921,960.88 |
| Advances to Suppliers |
251,485,005.60 |
| Other Receivables |
31,787,027.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,026,891,040.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
19,213,118.42 |
| Total Current Assets |
3,129,486,406.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
31,512,433.31 |
| Investment Properties |
7,022,737.22 |
| Fixed Assetes |
1,513,655,853.47 |
| Under-construction Projects |
62,181,329.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
329,299,987.14 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,852,121.26 |
| Deferred Income Tax Assets |
33,278,894.20 |
| Other Non-Current Assets |
85,441,466.29 |
| Sub-Total of Non-Current Assets |
2,068,632,532.73 |
| Total Assets |
5,198,118,939.22 |
| Short-Term Loans |
1,176,440,023.05 |
| Trading Financial liabilities |
-- |
| Notes Payable |
14,587,000.00 |
| Accounts Payable |
310,626,466.58 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,877,662.83 |
| Taxes Payable |
22,708,137.82 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
125,088,531.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
27,100,000.00 |
| Other Current Liabilities |
27,549,357.00 |
| Sub-Total of Current Liabilities |
1,921,895,309.23 |
| Long-term Loans |
673,338,002.84 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,861,761.95 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
726,528,791.03 |
| Total Liabilities |
2,648,424,100.26 |
| Paid-In Capital(Or Share Stock) |
360,000,000.00 |
| Capital Surplus |
440,961,728.89 |
| Surplus Reserve |
272,177,608.72 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,138,547,172.33 |
| Minority Stockholder's Interest |
354,596,599.87 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,195,098,239.09 |
| Owner's Equity（Stockholder's Equity） |
2,549,694,838.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,198,118,939.22 |
